Oxybutynin

Common brands: Oxytrol For Women, Oxytrol, Neurontin, Acid Reducer, Vitamin D

Top reporter: Allergan, Inc.

Cholinergic Muscarinic Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Proton Pump Inhibitor [EPC]Benzodiazepine [EPC]Provitamin D2 Compound [EPC]
28,767
Total Reports
7,312
Serious Reports
1,677
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.83%)

Patient Demographics

Male
6,016
Female
21,135

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Oxybutynin.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 3,945
13.5%
2 FATIGUE 1,551
5.3%
3 FALL 1,482
5.1%
4 OFF LABEL USE 1,261
4.3%
5 NAUSEA 1,224
4.2%
6 DIZZINESS 1,151
4.0%
7 DIARRHOEA 1,097
3.8%
8 PAIN 1,094
3.8%
9 URINARY TRACT INFECTION 1,052
3.6%
10 HEADACHE 1,002
3.4%
11 PRURITUS 995
3.4%
12 APPLICATION SITE ERYTHEMA 921
3.2%
13 ASTHENIA 898
3.1%
14 RASH 815
2.8%
15 PRODUCT ADHESION ISSUE 800
2.7%
16 DYSPNOEA 761
2.6%
17 CONSTIPATION 735
2.5%
18 GAIT DISTURBANCE 723
2.5%
19 MALAISE 719
2.5%
20 VOMITING 694
2.4%
21 DEATH 687
2.4%
22 DRY MOUTH 684
2.3%
23 ERYTHEMA 654
2.2%
24 DRUG EFFECT DECREASED 635
2.2%
25 PNEUMONIA 615
2.1%
26 APPLICATION SITE PRURITUS 603
2.1%
27 ARTHRALGIA 602
2.1%
28 WEIGHT DECREASED 585
2.0%
29 PAIN IN EXTREMITY 578
2.0%
30 CONDITION AGGRAVATED 559
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.